72 related articles for article (PubMed ID: 31332726)
1. DNA Methylation in
Katzendorn O; Peters I; Dubrowinskaja N; Moog JM; Reese C; Tezval H; Faraj Tabrizi P; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008203
[TBL] [Abstract][Full Text] [Related]
2. Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma.
Zheng X; Wezel F; Azoitei A; Meessen S; Wang W; Najjar G; Wang X; Kraus JM; Kestler HA; John A; Zengerling F; Bolenz C; Günes C
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359672
[TBL] [Abstract][Full Text] [Related]
3. Differential Diagnosis between Oral Metastasis of Renal Cell Carcinoma and Salivary Gland Cancer.
Morita Y; Kashima K; Suzuki M; Kinosada H; Teramoto A; Matsumiya Y; Uzawa N
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33809250
[TBL] [Abstract][Full Text] [Related]
4. Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach.
Iacobas DA; Mgbemena VE; Iacobas S; Menezes KM; Wang H; Saganti PB
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33302383
[TBL] [Abstract][Full Text] [Related]
5. Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.
Wang L; Li Y; Lyu Y; Wen H; Feng C
Cancer Cell Int; 2020; 20():482. PubMed ID: 33041663
[TBL] [Abstract][Full Text] [Related]
6. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
7. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
Di Nunno V; Mollica V; Brunelli M; Gatto L; Schiavina R; Fiorentino M; Santoni M; Montironi R; Caliò A; Eccher A; Milella M; Martignoni G; Brunocilla E; Massari F
Mol Diagn Ther; 2019 Oct; 23(5):569-577. PubMed ID: 31332726
[TBL] [Abstract][Full Text] [Related]
8. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract][Full Text] [Related]
13. Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice.
Salgia M; Adashek J; Bergerot P; Pal SK
Kidney Cancer; 2017 Nov; 1(2):99-105. PubMed ID: 30334011
[TBL] [Abstract][Full Text] [Related]
14. Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.
Lalani AA; McGregor BA; Albiges L; Choueiri TK; Motzer R; Powles T; Wood C; Bex A
Eur Urol; 2019 Jan; 75(1):100-110. PubMed ID: 30327274
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
